TARYN HARRELL: Open Payments
NPI 1346858479 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$403 in 24 payments from 13 companies in 2025. Trend: 2023 $246 · 2024 $191 · 2025 $403
Food & beverage: $403
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $81 |
| Corcept Therapeutics | 3 | $48 |
| ABBVIE INC. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| Novo Nordisk Inc | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| 180 Medical, Inc. | 1 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: Korlym, OTEZLA, EVENITY, MOUNJARO, Wegovy, TRINTELLIX, SHINGRIX, RECORLEV.
Industry payments across IN — which companies pay providers there.
